Form 4 for URGN UroGen Pharma Ltd.
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-18 · accession 0001209191-21-065756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-19 | 2021-11-18 | URGN | Schoenberg Mark | Chief Medical Off | P - Purchase | $13.10 | +160 | 22.0K | +0.7% | +$2,096 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-11-18 | P | A | 160 | $13.10 | 21,997 | D | — | — |